; however, very few reports are available on the prevalence of the MTHFR C677T polymorphism in fetal loss. The prevalence of these 2 mutations in Asian Indians with recurrent fetal loss has not yet been studied. In light of this, the present study was conducted on 85 women with spontaneous recurrent abortions.
Material and Methods

Participants
The present study was conducted on 85 women (Table 1) with spontaneous recurrent abortions (mean number of recurrent abortions, 3) , in whom acquired causes of recurrent abortions such as lupus anticoagulant and systemic/gynecological/fetal causes were excluded. Of the 85 patients, 40 had 2 abortions, R ecurrent fetal loss is a frequent health problem, with 3 or more affecting 1% to 2% and 2 or more affecting up to 5% of women of reproductive age. 1 Although a large number of reasons may be attributed to this problem, data accumulated over the past few years suggest a possible correlation between thrombophilia and fetal loss. Although a clear association has been established between fetal loss and certain thrombophilic states, such as antiphospholipid antibody syndromes, antithrombin deficiency, and combined defects, 2 reports on the prevalence of inherited prothrombotic defects such as factor V (FV) Leiden mutation and methylene tetrahydrofolate reductase (MTHFR) polymorphism in fetal loss are contradictory.
Recurrent fetal loss is a frequent health problem. Data accumulated over the past few years have suggested a possible correlation between thrombophilia and fetal loss. Although a clear association has been established between fetal loss and certain thrombophilic states, such as antiphospholipid antibody syndromes, antithrombin deficiency, and combined defects, reports on the prevalence of inherited prothrombotic defects such as factor V Leiden mutation and methylene tetrahydrofolate reductase C677T polymorphism in fetal loss are contradictory. The prevalence of these 2 mutations in Asian Indians with recurrent fetal loss has not yet been studied. In light of this, the present study looked at the prevalence of these mutations in 85 patients with spontaneous recurrent abortion and 31 controls. The authors did not find any significant role of these mutations in the development of recurrent abortion.
Keywords: recurrent fetal loss; FV Leiden; thrombophilia; MTHFR C677T polymorphism; maternal blood 28 had 3 abortions, and 12 had more than 3 abortions. Fifty-four out of the 85 had second trimester and the remaining 31, first trimester miscarriages. Thirtyone controls were also studied. The control group consisted of women who had at least 1 successful pregnancy. They were selected from unrelated attendants of the patients. They had no personal or family history of thrombosis.
Genotype Screening
Genomic DNA was extracted from peripheral blood leukocytes by standard phenol chloroform methods. Factor V Leiden Hong Kong/Cambridge mutation and MTHFR C677T polymorphism were determined using the restriction enzymes MnlI and HinfI, respectively, per previously described procedures.
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Results
Factor V Leiden mutation was seen in 2 patients ( Table 2) . None of the controls showed either the heterozygous or the homozygous mutant form. MTHFR C677T was positive in 11 (12.9%) of the patients. None of the patients or controls was positive for the factor V Hong Kong or Cambridge mutations. Although none of the controls was positive for the homozygous MTHFR C6777T polymorphism, heterozygosity for this polymorphism was seen in 8 (25.8%) of the controls. A chi-square test was used to test any significant difference in the prevalence of the mutations/polymorphisms between patients and controls. Odds ratios were used as a measure of the strength of the association. All P values were 2-tailed, and 95% confidence intervals were calculated.
Discussion
There was no significant difference in the prevalence of FV Leiden mutation between patients and controls (P = .77, odds ratio = 1.8). It was found to be positive in only 2 (2.35%) patients. Both were heterozygous for this mutation. None of the controls was positive for the mutation. Studies on the Western population have shown variable results. Although a study by Mtiraoui et al (2005) 7 has found a very high percentage of patients with FV Leiden mutation (20.54%), others such as Wolf et al (2003) 11 have shown a lower percentage of this mutation in patients with spontaneous recurrent abortions. Both studies, however, showed a significant association of FV Leiden mutation, unlike our study, in which we found no significant association. Our results are similar to another study from Turkey, 12 which showed no significant association between recurrent abortions and pregnancy loss. The patients with FV Leiden mutations had second-trimester pregnancy loss; no patient with first-trimester pregnancy loss had the mutation. This may be expected in that there is little chance that the FV Leiden mutation is involved in pregnancy loss before the 10th week of gestation, when maternal blood is not still in contact with trophoblast cells. 5 To account for the low prevalence of FV Leiden mutation in Asian Indians in comparison with the Caucasian population, we checked the Hong Kong/Cambridge mutation in our patient and control populations; however, we found no patient or control positive for these mutations. MTHFR C677T is another polymorphism that is frequently associated with thrombosis, 13 especially arterial thrombosis. There are reports of this polymorphism occurring along with the FV Leiden mutation in the homozygous or heterozygous form in the thrombophilic condition. This was the reason we chose to investigate this putative marker along with FV Recurrent Abortions in Asian Indians / Biswas et al 103 Leiden mutation in this study. Although we found no homozygous variant for this polymorphism in our patient population, the heterozygosity among the patient population (12.9%) also was not significantly different than that of the controls (25.8%; P = .16, odds ratio = 0.42). Studies from other parts of the world have shown variable results. A recent study from Brazil 14 showed a positive association of recurrent abortions with MTHFR C677T polymorphism. Studies closer to home, that is, in the Japanese population, have shown no association with this polymorphism. 15 A higher level of heterozygosity in the controls seen in this study brings into the picture the possibility that this polymorphism may in fact have a protective role for recurrent abortions in that it may protect against bleeding at an early stage of pregnancy. However, this study does not include an analysis into the homocysteine levels or for that matter vitamin B12 or folate status of the patients, without which it would be impossible to draw a final conclusion to this possibility. In conclusion, we report that unlike in the West, where recurrent spontaneous abortion has been seen to be frequently associated with FV Leiden and MTHFR C677T polymorphism, it is unlikely that these mutations have a role in pregnancy loss in Asian Indians.
